Aggregate National Experience With the Wearable Cardioverter-Defibrillator

Chung, Mina K.; Szymkiewicz, Steven J.; Shao, Mingyuan; Zishiri, Edwin; Niebauer, Mark J.; Lindsay, Bruce D.; Tchou, Patrick J.

doi:10.1016/j.jacc.2010.04.016

Cited by 297Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationCardiac electrophysiology and arrhythmias

Aggregate National Experience With the Wearable Cardioverter-Defibrillator

Open access

Chung, Mina K., Szymkiewicz, Steven J., Shao, Mingyuan, Zishiri, Edwin, Niebauer, Mark J., Lindsay, Bruce D., Tchou, Patrick J.·2010·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2010.04.016PMC PMC2962668

Open this paper in CoChat — free account

Abstract

Objectives The purpose of this study was to determine patient compliance and effectiveness of antiarrhythmic treatment by the wearable cardioverter-defibrillator (WCD).Background Effectiveness of the WCD for prevention of sudden death is dependent on event type, patient compliance, and appropriate management of ventricular tachycardia/ventricular fibrillation (VT/VF).Methods Compliance and events were recorded in a nationwide registry of post-market release WCDs. Survival, using the Social Security Death Index, was compared with survival in implantable cardioverter-defibrillator (ICD) patients.Results Of 3,569 patients wearing the WCD (age 59.3+/-14.7 years, duration 52.6+/-69.9 days), daily use was 19.9+/-4.7 h (>90% of the day) in 52% of patients. More days of use correlated with higher daily use (p<0.001). Eighty sustained VT/VF events occurred in 59 patients (1.7%). First-shock success was 76 of 76 (100%) for unconscious VT/VF and 79 of 80 (99%) for all VT/VF. Eight patients died after successful conversion of unconscious VT/VF (89.5% survival of VT/VF events). Asystole occurred in 23 (17 died), pulseless electrical activity in 2, and respiratory arrest in 1 (3 died), representing 24.5% of sudden cardiac arrests. During WCD use, 3,541 of 3,569 patients (99.2%) survived overall. Survival occurred in 72 of 80 (90%) VT/VF events and 78 of 106 (73.6%) for all events. Long-term mortality was not significantly different from first ICD implant patients but highest among patients with traditional ICD indications.Conclusions Compliance was satisfactory with 90% wear time in >50% of patients and low sudden death mortality during use. Survival was comparable to that of ICD patients. However, asystole was an important cause of mortality in sudden cardiac arrest events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.04.016

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

LifeVest showed comparable outcomes to implantable cardiac devices in a 3-year study (n = 3569) with acute event survival at 99.2%.
“LiveVest showed comparable outcomes to implantable cardiac devices in a 3-year study (n = 3569) with acute event survival at 99.2% [38].”
From Wearables and the Medical Revolution (2018) · cites this paper as [38]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885 · see citing works
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552 · see citing works
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165 · see citing works
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221 · see citing works
PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION
Oss, J. M., Areba, W. O. Z., Ackson, W. J., Lein, H. E. K., Ilber, D. A. J. W., Annom, D. A. S. C., Ames, J. M., Aubert, P., Iggins, S. T. L. H., Rown, M. A. W. B., et al. (2002) · Cited by 2,026 · see citing works
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519 · see citing works
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Solomon, S. D., Zelenkofske, S., McMurray, J. J. V., Finn, P. V., Velazquez, E. J., Ertl, G., Harsanyi, A., Rouleau, J. L., Maggioni, A. P., Køber, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043938 · Cited by 802 · see citing works
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
Ho, P. M., Spertus, J. A., Masoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Krumholz, H. M., & Rumsfeld, J. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1842 · Cited by 635 · see citing works
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
(2005) · New England Journal of Medicine · doi:10.1056/nejm200508183530725 · Cited by 601 · see citing works
Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis
Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255 · see citing works
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
Germano, J. J., Reynolds, M. R., Essebag, V., & Josephson, M. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.048 · Cited by 218 · see citing works
Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:
Feldman, A. M., Klein, H., TCHOU, P. J., Murali, S., Hall, W. J., MANCINI, D. M., BOEHMER, J. P., Harvey, M. N., Heilman, M. S., Szymkiewicz, S. J., et al. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00378.x · Cited by 211 · see citing works
Self-citation
Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone
Bokhari, F., Newman, D. M., Greene, M., Korley, V. J., Mangat, I., & Dorian, P. (2004) · Circulation · doi:10.1161/01.cir.0000134957.51747.6e · Cited by 180 · see citing works
Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
Klein, R. C., Raitt, M. H., Wilkoff, B. L., Beckman, K. J., Coromilas, J., Wyse, D. G., Friedman, P. L., Martins, J. B., Epstein, A. E., Hallstrom, A. P., et al. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.01554.x · Cited by 179 · see citing works
Clinical Efficacy of a Wearable Defibrillator in Acutely Terminating Episodes of Ventricular Fibrillation Using Biphasic Shocks
Reek, S., Geller, J. C., Meltendorf, U., WOLLBRUECK, A., Szymkiewicz, S. J., & Klein, H. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.00311.x · Cited by 86 · see citing works
Self-citation
A Fatal Device‐Device Interaction between a Wearable Automated Defibrillator and a Unipolar Ventricular Pacemaker
LaPage, M. J., Canter, C. E., & Rhee, E. K. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01110.x · Cited by 42 · see citing works

Flagged first, then by citations

Sorted by citations

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429 · see citing works
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879 · see citing works
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866 · see citing works
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893 · see citing works
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644 · see citing works
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,883 · see citing works
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,667 · see citing works
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 750 · see citing works
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 730 · see citing works
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 685 · see citing works
Wearables and the Medical Revolution
Dunn, J., Runge, R., & Snyder, M. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0044 · Cited by 654 · see citing works
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 639 · see citing works
Declining Risk of Sudden Death in Heart Failure
Shen, L., Jhund, P. S., Petrie, M. C., Claggett, B. L., Barlera, S., Cleland, J. G. F., Dargie, H. J., Granger, C. B., KJEKSHUS, J. K., Køber, L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609758 · Cited by 518 · see citing works
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412 · see citing works
Self-powered cardiovascular electronic devices and systems
Zheng, Q., Tang, Q., Wang, Z. L., & Li, Z. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0426-4 · Cited by 348 · see citing works
Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association
Sandau, K. E., Funk, M., Auerbach, A. D., Barsness, G. W., Blum, K., Cvach, M. M., Lampert, R., May, J. L., McDaniel, G. M., Perez, M. V., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000527 · Cited by 354 · see citing works
Wearable Cardioverter–Defibrillator after Myocardial Infarction
Olgin, J. E., Pletcher, M. J., Vittinghoff, E., Wranicz, J. K., Malik, R. K., Morin, D. P., ZWEIBEL, S. L., Buxton, A. E., Elayi, C. S., Chung, E. H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800781 · Cited by 288 · see citing works
Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)
Kutyifa, V., Moss, A. J., Klein, H., Biton, Y., McNitt, S., MacKecknie, B., Zareba, W., & Goldenberg, I. (2015) · Circulation · doi:10.1161/circulationaha.115.015677 · Cited by 243 · see citing works
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 203 · see citing works
Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction
Epstein, A. E., Abraham, W. T., Bianco, N. R., Kern, K. B., Mirro, M. J., Rao, S. V., Rhee, E. K., Solomon, S. D., & Szymkiewicz, S. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.086 · Cited by 186 · see citing works
Self-citation
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Kusumoto, F. M., Calkins, H. G., BOEHMER, J. P., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J. H., Lee, R., Mehra, M. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.008 · Cited by 169 · see citing works
Self-citation
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 164 · see citing works
Risk for Ventricular Fibrillation in Peripartum Cardiomyopathy with Severely Reduced Left Ventricular Function—Value of the Wearable Cardioverter/Defibrillator
Duncker, D., Haghikia, A., König, T., Hohmann, S., Gutleben, K., Westenfeld, R., Oswald, H., Klein, H., Bauersachs, J. K., Hilfiker‐Kleiner, D., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.188 · Cited by 158 · see citing works
Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction
Martens, P., Nuyens, D., Rivero‐Ayerza, M., Herendael, H. V., Vercammen, J., Ceyssens, W., Luwel, E., Dupont, M., & Müllens, W. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01440-y · Cited by 155 · see citing works
Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator
Zishiri, E. T., Williams, S., Cronin, E. M., Blackstone, E. H., Ellis, S. G., Roselli, E. E., Smedira, N. G., Gillinov, A. M., Glad, J. A., TCHOU, P. J., et al. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.973552 · Cited by 132 · see citing works
Self-citation
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Kusumoto, F. M., Calkins, H. G., BOEHMER, J. P., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J. H., Lee, R., Mehra, M. R., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000056 · Cited by 132 · see citing works
Self-citation
Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
Wäßnig, N. K., Günther, M., Quick, S., Pfluecke, C., Rottstädt, F., Szymkiewicz, S. J., Ringquist, S., Strasser, R. H., & Speiser, U. (2016) · Circulation · doi:10.1161/circulationaha.115.019124 · Cited by 125 · see citing works
Self-citation
Sudden Cardiac Death Early After Myocardial Infarction
Zaman, S. J., & Kovoor, P. (2014) · Circulation · doi:10.1161/circulationaha.113.007497 · Cited by 126 · see citing works
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Piccini, J. P., Allen, L. A., Kudenchuk, P. J., Page, R. L., Patel, M. R., & Turakhia, M. P. (2016) · Circulation · doi:10.1161/cir.0000000000000394 · Cited by 126 · see citing works
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, A. J., Elliot, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.recesp.2016.01.001 · Cited by 136 · see citing works
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 118 · see citing works
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
Klein, H., Goldenberg, I., & Moss, A. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht167 · Cited by 115 · see citing works
Characteristics and Outcomes of Peripartum Versus Nonperipartum Cardiomyopathy in Women Using a Wearable Cardiac Defibrillator
Saltzberg, M., Szymkiewicz, S. J., & Bianco, N. R. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.09.004 · Cited by 103 · see citing works
Self-citation
Wearable Sensing Devices for Point of Care Diagnostics
Mondal, S., Zehra, N., Choudhury, A., & Iyer, P. K. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00798 · Cited by 100 · see citing works
Sustained Ventricular Tachycardia and Ventricular Fibrillation Complicating Non–ST-Segment–Elevation Acute Coronary Syndromes
Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y. V., Al‐Khatib, S. M., Tricoci, P., Pollack, C. V., Montalescot, G., de Werf, F. V., Gibson, C. M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.071860 · Cited by 90 · see citing works
Impact of wearable cardioverter‐defibrillator compliance on outcomes in the VEST trial: As‐treated and per‐protocol analyses
Olgin, J. E., Lee, B. K., Vittinghoff, E., Morin, D. P., ZWEIBEL, S. L., Rashba, E. J., Chung, E. H., Borggrefe, M., Hulley, S. B., Lin, F., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14404 · Cited by 86 · see citing works
Prognostic Significance of Postprocedural Sustained Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial)
Mehta, R. H., Yu, J., Piccini, J. P., Tcheng, J. E., Farkouh, M. E., Reiffel, J. A., Fahy, M. P., Mehran, R., & Stone, G. W. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.043 · Cited by 84 · see citing works
The wearable cardioverter-defibrillator: current technology and evolving indications
Reek, S., Burri, H., Roberts, P. R., Perings, C. A., Epstein, A. E., Klein, H., Lip, G. Y. H., Görenek, B., Sticherling, C., Fauchier, L., et al. (2016) · EP Europace · doi:10.1093/europace/euw180 · Cited by 80 · see citing works
Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
Wan, C., Herzog, C. A., Zaręba, W., & Szymkiewicz, S. J. (2013) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12119 · Cited by 69 · see citing works
Self-citation
Subcutaneous Implantable Cardioverter Defibrillator
Rowley, C. P., & Gold, M. R. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.964676 · Cited by 61 · see citing works
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Masri, A., Altibi, A. M. A., Erqou, S. A., Zmaili, M. A., Saleh, A. M., Al-Adham, R., Ayoub, K. F., Baghal, M., Alkukhun, L., Barakat, A. F., et al. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.11.011 · Cited by 60 · see citing works
Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis
Opreanu, M., Wan, C., Singh, V., Salehi, N., Ahmad, J., Szymkiewicz, S. J., & Thakur, R. K. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.04.004 · Cited by 59 · see citing works
Self-citation
Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy
Singh, M., Wang, N. C., Jain, S. K., Voigt, A., Saba, S., & ADELSTEIN, E. C. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.079 · Cited by 57 · see citing works
Cardiac Implantable Electronic Device Therapy in Heart Failure
Hussein, A. A., & Wilkoff, B. L. (2019) · Circulation Research · doi:10.1161/circresaha.118.313571 · Cited by 53 · see citing works
Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant
Ellenbogen, K. A., Koneru, J. N., Sharma, P. S., Deshpande, S. V., Wan, C., & Szymkiewicz, S. J. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.09.002 · Cited by 54 · see citing works
Self-citation
Wearable Cardioverter-Defibrillators
Adler, A., Halkin, A., & Viskin, S. (2013) · Circulation · doi:10.1161/circulationaha.112.146530 · Cited by 51 · see citing works
2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure.
Wang, C. C., Wu, C., Tsai, M., Lee, C., Huang, W. C., Chou, H., Huang, J. L., Chi, N., Yen, H., Tzeng, B., et al. (2019) · PubMed Central · doi:10.6515/acs.201905_35(3).20190422a · Cited by 50 · see citing works
Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation
Healy, C. A., & Carrillo, R. G. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.061 · Cited by 48 · see citing works
Normalization of Left Ventricular Ejection Fraction after Cardiac Resynchronization Therapy Also Normalizes Survival
Manne, M. B., Rickard, J., Varma, N., Chung, M. K., & TCHOU, P. J. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12174 · Cited by 46 · see citing works
Self-citation
The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: Implications for timing of implantable cardioverter-defibrillator implantation
Teeter, W. A., Thibodeau, J. T., Rao, K. K., Brickner, M. E., Toto, K. H., Nelson, L. L., Mishkin, J. D., Ayers, C. R., Miller, J. G., Mammen, P. P. A., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.009 · Cited by 44 · see citing works
Wearable defibrillator use in heart failure (WIF): results of a prospective registry
the Wearable defibrillator use In heart Failure (WIF) Investigators, Kao, A. C., Krause, S. W., Handa, R., Karia, D. H., Reyes, G., Bianco, N. R., & Szymkiewicz, S. J. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-123 · Cited by 44 · see citing works
Self-citation
The Role of the Wearable Cardioverter Defibrillator in Clinical Practice
Chung, M. K. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2013.11.002 · Cited by 42 · see citing works
Self-citation
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Kusumoto, F. M., Calkins, H. G., BOEHMER, J. P., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J. H., Lee, R., Mehra, M. R., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.041 · Cited by 41 · see citing works
Self-citation
Protection from Outpatient Sudden Cardiac Death following ICD Removal Using a Wearable Cardioverter Defibrillator
Tanawuttiwat, T., Garisto, J., Salow, A. D., Glad, J. A., Szymkiewicz, S., SALTZMAN, H. E., Kutalek, S. P., & Carrillo, R. G. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12319 · Cited by 40 · see citing works
Self-citation
Defibrillators
Al‐Khatib, S. M., Friedman, P. A., & Ellenbogen, K. A. (2016) · Circulation · doi:10.1161/circulationaha.116.021889 · Cited by 39 · see citing works
Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients: Review and Recommendations for Practice
Saad, T. F., Hentschel, D. M., Koplan, B. A., Wasse, H., Asif, A., Patel, D. V., Salman, L. H., Carrillo, R. G., & Hoggard, J. G. (2012) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2012.01103.x · Cited by 40 · see citing works
Wearable Defibrillator in Congenital Structural Heart Disease and Inherited Arrhythmias
Rao, M. C., Goldenberg, I., Moss, A. J., Klein, H., Huang, D. T.-C., Bianco, N. R., Szymkiewicz, S. J., Zaręba, W., brenyo, A. J., Buber, J., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.021 · Cited by 39 · see citing works
Self-citation
The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients
Erath, J. W., Vámos, M., Sirat, A. S., & Hohnloser, S. H. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1054-1 · Cited by 39 · see citing works
Arrhythmias in Peripartum Cardiomyopathy
Honigberg, M. C., & Givertz, M. M. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.03.010 · Cited by 37 · see citing works
Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012
McMurray, J. J. V., Adamopoulos, S. N., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G. S., Fonseca, C., Sánchez, M. Á. G., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.08.003 · Cited by 34 · see citing works
Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
Veltmann, C., Winter, S., Duncker, D., Jungbauer, C. G., Wäßnig, N. K., Geller, J. C., Erath, J. W., Göing, O., Perings, C. A., Ulbrich, M., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01657-2 · Cited by 34 · see citing works
Usefulness of the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
Sasaki, S., Tomita, H., Shibutani, S., Izumiyama, K., Higuma, T., Itoh, T., Sasaki, K., Horiuchi, D., Kimura, M., & Okumura, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-1098 · Cited by 33 · see citing works
Digital monitoring and care: Virtual medicine
Shinbane, J. S., & Saxon, L. A. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.05.007 · Cited by 31 · see citing works
Present Guidelines for Device Implantation
Poole, J. E. (2014) · Circulation · doi:10.1161/circulationaha.112.000762 · Cited by 30 · see citing works
Factors associated with re-arrest following initial resuscitation from cardiac arrest
Bhardwaj, A., Ikeda, D. J., Grossestreuer, A. V., Sheak, K. R., Delfin, G., Layden, T., Abella, B. S., & Leary, M. (2016) · Resuscitation · doi:10.1016/j.resuscitation.2016.12.007 · Cited by 30 · see citing works
Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting
Röger, S., Rosenkaimer, S. L., Hohneck, A. L., Lang, S., El‐Battrawy, I., Rudic, B., Tülümen, E., Stach, K., Kuschyk, J., Akın, İ., et al. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0790-8 · Cited by 30 · see citing works
Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis
Nguyen, E., Weeda, E. R., Kohn, C. G., D'Souza, B. A., Russo, A. M., Noreika, S., & Coleman, C. I. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090506 · Cited by 30 · see citing works
The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis
Salehi, N., Nasiri, M., Bianco, N. R., Opreanu, M., Singh, V., Satija, V., Jhand, A., Karapetyan, L., Safadi, A. R., Surapaneni, P. K., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.12.035 · Cited by 29 · see citing works
Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry
Odeneg, T., Ebner, C., Mörtl, D., Keller, H., Dirninger, A., Stix, G., Föger, B., Grimm, G., Steinwender, C., Gebetsberger, F., et al. (2018) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515118790365 · Cited by 28 · see citing works
Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial Infarction
Ye, S., Grunert, M., Thune, J. J., Stephenson, K., Uno, H., Finn, P. V., McMurray, J. J. V., Velazquez, E. J., Califf, R. M., Pfeffer, M. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.990655 · Cited by 27 · see citing works
Ten advances defining sudden cardiac death
Mitrani, R. D., & Myerburg, R. J. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.03.017 · Cited by 27 · see citing works
Indications and use of the wearable cardiac defibrillator
Sharma, P. S., Bordachar, P., & Ellenbogen, K. A. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw353 · Cited by 25 · see citing works
Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction
Elayi, C. S., Charnigo, R. J., Heron, P. M., Lee, B. K., & Olgin, J. E. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005194 · Cited by 29 · see citing works
Heart Failure and Sudden Cardiac Death
Saour, B., Smith, B., & Yancy, C. W. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.07.010 · Cited by 26 · see citing works
Extended Follow-Up After Wearable Cardioverter-Defibrillator Period: The PROLONG-II Study
Müller‐Leisse, J., Brunn, J., Zormpas, C., Hohmann, S., Hillmann, H. A. K., Eiringhaus, J., Bauersachs, J. K., Veltmann, C., & Duncker, D. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13586 · Cited by 25 · see citing works
Usefulness of the wearable cardioverter defibrillator in patients in the early post‐myocardial infarction phase with high risk of sudden cardiac death: A single‐center European experience
Kondo, Y., Linhart, M., Andrié, R., & SCHWAB, J. O. (2015) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.03.007 · Cited by 23 · see citing works
The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients
Spar, D. S., Bianco, N. R., Knilans, T. K., Czosek, R. J., & Anderson, J. B. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.006163 · Cited by 23 · see citing works
Current Device Therapies for Sudden Cardiac Death Prevention – the ICD, Subcutaneous ICD and Wearable ICD
Chieng, D., Paul, V., & Denman, R. A. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.011 · Cited by 23 · see citing works
The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
Rosenkaimer, S., El‐Battrawy, I., Dreher, T. C., Gerhards, S., Röger, S., Kuschyk, J., Borggrefe, M. M., & Akın, İ. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030893 · Cited by 23 · see citing works
The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey
Lenarczyk, R., Potpara, T., Haugaa, K. H., Hernández‐Madrid, A., Sciaraffia, E., & Dagres, N. (2016) · EP Europace · doi:10.1093/europace/euw003 · Cited by 22 · see citing works
Wearable cardioverter-defibrillators: A review of evidence and indications
Cheung, C. C., Olgin, J. E., & Lee, B. K. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.03.002 · Cited by 22 · see citing works
New horizon for infection prevention technology and implantable device
Kondo, Y., Ueda, M., Kobayashi, Y., & SCHWAB, J. O. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.02.007 · Cited by 21 · see citing works
Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
Skowasch, D., Ringquist, S., Nickenig, G., & Andrié, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194496 · Cited by 21 · see citing works
Cardiac strangulation from epicardial pacemaker leads: diagnosis, treatment, and prevention
Takeuchi, D., & Tomizawa, Y. (2014) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-014-0483-x · Cited by 21 · see citing works
Alzheimer?s disease: the impact of age-related changes in reproductive hormones
Atwood, C. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4380-4 · Cited by 20 · see citing works
Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
Kutyifa, V., Vermilye, K., Daimee, U. A., McNitt, S. A., Klein, H., & Moss, A. J. (2018) · EP Europace · doi:10.1093/europace/euy091 · Cited by 19 · see citing works
Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study
Garcia, R., Warming, P. E., Narayanan, K., Defaye, P., Guédon-Moreau, L., Blangy, H., Piot, O., Leclercq, C., Marijon, É., the WEARIT-France Investigators, et al. (2023) · EP Europace · doi:10.1093/europace/euad062 · Cited by 20 · see citing works
Wearable cardioverter defibrillator: A life vest till the life boat (ICD) arrives
Francis, J., & Reek, S. (2014) · Indian Heart Journal · doi:10.1016/j.ihj.2013.12.050 · Cited by 19 · see citing works
One‐year follow‐up of the prospective registry of patients using the wearable defibrillator (WEARIT‐II Registry)
Kutyifa, V., Moss, A. J., Klein, H., McNitt, S. A., Zaręba, W., & Goldenberg, I. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13448 · Cited by 19 · see citing works
Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study
Ettinger, S., Stanak, M., Szymański, P., Wild, C., Haček, R. T., Erčević, D., Grenković, R., & Huić, M. (2017) · Medical Devices Evidence and Research · doi:10.2147/mder.s144048 · Cited by 18 · see citing works
The Wearable Cardioverter Defibrillator: an Early Single Centre Australian Experience. Some Pitfalls and Caveats for Use
Bhaskaran, A. P., Bartlett, M., Kovoor, P., & Davis, L. M. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.07.011 · Cited by 18 · see citing works
Wearable defibrillators in uninsured patients with newly diagnosed cardiomyopathy or recent revascularization in a community medical center
Mitrani, R. D., Mcardle, A., Slane, M., Cogan, J., & Myerburg, R. J. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.12.014 · Cited by 18 · see citing works
National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy
Lamichhane, M., Gardiner, J. C., Bianco, N. R., Szymkiewicz, S. J., & Thakur, R. K. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0194-6 · Cited by 18 · see citing works
Self-citation
Wearable Cardioverter Defibrillator “The Lifevest”: Device Design, Limitations, and Areas of Improvement.
Agarwal, M. A., Narcisse, D. I., Khouzam, N., & Khouzam, R. N. (2017) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2017.04.002 · Cited by 18 · see citing works
Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD
Kaspar, G., Sanam, K., Gholkar, G., Bianco, N. R., Szymkiewicz, S. J., & Shah, D. P. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.017 · Cited by 18 · see citing works
Self-citation
Wearable cardioverter defibrillators for patients with long QT syndrome
Owen, H. J., Bos, J. M., & Ackerman, M. J. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.002 · Cited by 17 · see citing works
A wearable cardioverter defibrillator with a low false alarm rate
Poole, J. E., Gleva, M. J., Birgersdotter-Green, U. M., Branch, K. R., Doshi, R. N., Salam, T., Crawford, T., Willcox, M. E., Sridhar, A. M., Mikdadi, G., et al. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15417 · Cited by 17 · see citing works
Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator
Goldenberg, I., Erath, J. W., Russo, A. M., Burch, A. E., Aßmus, B., Bonderman, D., McNitt, S. A., & Kutyifa, V. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.11.025 · Cited by 17 · see citing works
The Wearable Cardioverter/Defibrillator - Toy Or Tool?
Duncker, D., & Veltmann, C. (2016) · PubMed Central · doi:10.4022/jafib.1367 · Cited by 16 · see citing works

P1022The effectiveness of the wearable cardioverter defibrillator in a real world environment
Bamimore, A., Kalamkarian, N., Olaniyi, O., Esan, O. O., Mitre, C. A., Abrahim, C., & Budzikowski, A. S. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy564.p1022
Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death
Weth, C., Abuazab, H., Ewen, S., Ukena, C., Böhm, M., & Custodis, F. (2021) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-021-00816-w · Cited by 3 · see citing works
2404The use of wearable cardioverter defibrillator in France
Marijon, É., Garcia, R., Gras, D., Sadoul, N., Guédon-Moreau, L., Leclercq, C., Extramiana, F., Lellouche, N., Defaye, P., & Combes, N. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz748.0157
The Wearable Cardioverter/ Defibrillator: retrospective analysis of efficacy, safety and adherence
Ehmsen, J. T., Keller, H., & Stoellberger, C. (2020) · European Heart Journal · doi:10.1093/ehjci/ehaa946.0407
Abstract 16709: Multicenter Assessment of Wearable Cardioverter Defibrillator Use in Patients at Risk of Sudden Cardiac Death: France National Experience
Marijon, É., Combes, N., Gras, D., Sadoul, N., Guédon-Moreau, L., Leclercq, C., Extramiana, F., Lellouche, N., & Defaye, P. (2018) · Circulation · doi:10.1161/circ.138.suppl_1.16709

Authors: Chung, M. K., Szymkiewicz, S. J., Shao, M., Zishiri, E., Niebauer, M. J., Lindsay, B. D., & Tchou, P. J.
Affiliations: Cleveland Clinic (US)
ZOLL Medical Corporation (United States) (US)
Corresponding author: Chung, Mina K.
ORCID: Chung, Mina K.
Szymkiewicz, Steven J.
Shao, Mingyuan
Zishiri, Edwin
Niebauer, Mark J.
Tchou, Patrick J.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2010-07
Volume: 56
Issue: 3
Pages: 194-203
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2010.04.016
PMC: PMC2962668
OpenAlex: W2159588890
Cited by: 297
References: 16
Citations by year: 2026: 5 · 2025: 6 · 2024: 9 · 2023: 15 · 2022: 11 · 2021: 19 · 2020: 26 · 2019: 21 · 2018: 28 · 2017: 33 · 2016: 39 · 2015: 20 · 2014: 14 · 2013: 19 · 2012: 13
FWCI: 10.98
Type: journal article
Language: en
Update notices: erratum (2011-01-11)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1111 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Medtronic, Inc.
Boston Scientific
St. Jude Medical
Biotronik
Medtronic
National Institutes of Health (NIH R01 HL090620)
ZOLL
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: wearable cardioverter defibrillator, medication adherence, sudden cardiac death prevention, ventricular tachycardia, ventricular fibrillation, implantable cardioverter-defibrillator, survival, asystole, sudden cardiac arrest, post-market registry
MeSH terms: Female, Humans, Male, Middle Aged, Patient Compliance, Ventricular Fibrillation, Death, Sudden, Cardiac, Tachycardia, Ventricular, Defibrillators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aggregate National Experience With the Wearable Cardioverter-Defibrillator

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks